Package 62135-706-37

{"route": ["ORAL"], "spl_id": "472f29d3-cf7e-0a76-e063-6294a90a9e7a", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0362135706371"], "unii": ["2T8Q726O95"], "rxcui": ["199148"], "spl_set_id": ["ef9977cb-ec91-46d7-b769-d26decfd6fe7"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (62135-706-24)  / 10 CUP in 1 TRAY / 30 mL in 1 CUP (62135-706-30)", "package_ndc": "62135-706-24", "marketing_start_date": "20250306"}, {"sample": false, "description": "240 mL in 1 BOTTLE, PLASTIC (62135-706-37)", "package_ndc": "62135-706-37", "marketing_start_date": "20230720"}], "brand_name": "lamivudine", "product_id": "62135-706_472f29d3-cf7e-0a76-e063-6294a90a9e7a", "dosage_form": "SOLUTION", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "62135-706", "generic_name": "lamivudine oral", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "10 mg/mL"}], "application_number": "ANDA203564", "marketing_category": "ANDA", "marketing_start_date": "20141031", "listing_expiration_date": "20261231"}